Ophthalmic

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601125TR, A61K 3700, C07C10352

Patent

active

041501209

ABSTRACT:
Eye diseases in mammals such as progressive cataract or conjunctivitis are effectively treated by administering to the mammals a thyroid stimulating hormone releasing hormone. The treatment effect is enhanced by the concomitant administration of the said hormone with an adrenocortica hormone.

REFERENCES:
patent: 3746697 (1973-07-01), Folkers et al.
patent: 3932623 (1976-01-01), Wilson
patent: 4059692 (1977-11-01), Takahashi

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ophthalmic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1262054

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.